Dietary catechin delays tumor onset in a transgenic mouse model

American Journal of Clinical Nutrition

Volumn 76, Issue 4, 2002, Pages 865-872

  Ebeler, Susan E ^a   Brenneman, Charles A ^a   Kim, Gap Soon ^a   Jewell, William T ^a   Webb, Michael R ^a   Chacon Rodriguez, Leticia ^a   MacDonald, Emily A ^a   Cramer, Amanda C ^a   Levi, Andrew ^a   Ebeler, John D ^a   Islas Trejo, Alma ^a   Kraus, Amber ^b   Hinrichs, Steven H ^b   Clifford, Andrew J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Amino acid based diet; Cancer; Catechin; Transgenic mice; Tumor onset; Wine

Indexed keywords

CATECHIN; POLYPHENOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FOOD PROCESSING; MOUSE; NONHUMAN; ONSET AGE; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; TRANSGENIC MOUSE; WINE;

ANIMALIA; MUS MUSCULUS;

EID: 0036784343     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/76.4.865     Document Type: Article

References (53)

1. Bailey GS, Williams DE. Potential mechanisms for food-related carcinogens and anticarcinogens. Food Technol 1993;47:105-18.
2. Willett WC. Diet and health: what should we eat? Science 1993; 254:532-7.
3. Grønbaek M, Deis A, Sorensen TIA, Becker U, Schnor P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 1995;310:1169-72.
4. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992; 17:1-29
5. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673-751.
6. Rice-Evans CA, Miller NJ, Bolwell GP, Bramley PM, Pridham JB. The relative antioxidant activities of plant derived polyphenolic flavonoids. Free Radic Res 1995;22:375-83.
7. Jovanovic SV, Steenken S, Tosic M. Flavonoids as antioxidants. J Am Chem Soc 1994;116:4846-51.
8. Newmark HL. Plant phenolic compounds as inhibitors of mutagenesis and carcinogenesis. In: Huang HT, Ho CT, Lee CY. eds. Phenolic compounds in food and their effects on health. Antioxidants and cancer prevention. Washington, DC: American Chemical Society, 1992: 48-53. (ACS Symposium Series 507.)
9. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring phenolic compound. Cancer Res 1995;55:259-6.
10. Ito N, Hirose M, Shirai T. Carcinogenicity and modification of carcinogenic response by plant phenols. In: Huang HT, Ho CT, Lee CY, eds. Phenolic compounds in food and their effects on health. Antioxidants and cancer prevention. Washington, DC: American Chemical Society, 1992:269-83. (ACS Symposium Series 507.)
11. Kelloff GJ, Boone CW, Steele VE, et al. Mechanistic considerations in chemopreventive drug development. J Cell Biochem Suppl 1994; 20:1-24.
12. Stavric B. Quercetin in our diet: from potent mutagen to probable anticarcinogen. Clin Biochem 1994;27:245-8.
13. 2 release is stimulated by wine in vitro: one mechanism that may mediate the vasoprotective effects of wine. Nutr Biochem 1997;8: 647-51.
14. Macheix JJ, Sapis JC, Fleuriet A. Phenolic compounds and polyphenoloxidase in relation to browning in grapes and wines. Crit Rev Food Sci Nutr 1991;30:441-86.
15. Singleton VL. Naturally occurring food toxicants: phenolic substances of plant origin common in foods. Adv Food Res 1981;27: 149-242.
16. Grønbaek M, Becker U, Johansen D, et al. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 2000;133:411-9.
17. Clifford AJ, Ebeler SE, Ebeler JD, et al. Delayed tumor onset in transgenic mice fed an amino acid-based diet supplemented with red wine solids. Am J Clin Nutr 1996;64:748-56.
18. Wilson DS, Bowen H, Pritsos CA. Effect of red wine consumption on the development of methylnitrosourea-induced mammary tumors in rats. Environ Nutr Interact 1999;3:233-44.
19. Donovan JL, Bell JR, Kasim-Karakas S, et al. Catechin is present as metabolites in human plasma after consumption of red wine. J Nutr 1999;129:1662-8.
20. Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G, Jay G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 1987;37:1324-9.
21. Zoecklein BW, Fugelsang KC, Gump BH, Nury FS. Wine analysis and production. New York: Chapman and Hall, 1995.
22. Lamuela-Raventos RM, Waterhouse AL. A direct HPLC separation of wine phenolics. Am J Enol Vit 1994;45:1-5.
23. Merlino G. Transgenic mice as models for tumorigenesis. Cancer Invest 1994;12:203-13.
24. Tennant R. Transgenic mouse models in chemical carcinogenesis studies. Arch Toxicol 1994;16:261-70.
25. Thomas H, Balkwill FR. Oncogene transgenic mice as therapeutic models in cancer research. Eur J Cancer 1994;30A:533-7.
26. Viney JL. Transgenic and gene knockout mice in cancer research. Cancer Metastasis Rev 1995;14:77-90.
27. Ebeler SE, Clifford AJ, Ebeler JD, Bills ND, Hinrichs SH. An in vivo experimental protocol for identifying and evaluating dietary factors that delay tumor onset: effect of red wine solids. In: Watkins TR, ed. Wine: nutritional and therapeutic benefits. Washington, DC: American Chemical Society, 1997:215-29.
28. Yamamoto S, Urano K, Koizumi H, et al. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ Health Perspect 1998;106:57-69.
29. Walzem RL, Clifford AJ. Thiamin absorption is not compromised in folate deficient rats. J Nutr 1988:118:1089-96.
30. Clifford AJ, Heid MK, Muller HG, Bills ND. Tissue distribution and prediction of total body folate of rats. J Nutr 1990;120:1633-9.
31. Bills ND, Hinrichs SH, Morgan R, Clifford AJ. Tissue folate levels in transgenic mice with tumors and in nontransgenic controls. J Natl Cancer Inst 1992;84:332-7.
32. Shaw IC, Griffiths LA. Identification of the major biliary metabolite of (+)-catechin in the rat. Xenobiotica 1980;10:905-11.
33. Hackett AM, Shaw IC, Griffiths LA. 3′-O-Methyl-(+)-catechin glucuronide and 3′-O-methyl-(+)-catechin sulphate: new urinary metabolites of (+)-catechin in the rat and the marmoset. Experientia 1982; 38:538-40.
34. Manach C, Texier O, Morand C, et al. Comparison of the bioavailability of quercetin and catechin in rats. Free Radic Biol Med 1999; 27:1259-66.
35. 14C]-cyanidanol-3 in man following oral administration. Xenobiotica 1983;13:279-83.
36. Kim S, Lee MJ, Hong J, et al. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer 2000;37:41-8.
37. Weyant MJ, Carothers AM, Dannenberg AJ, Bertagnolli MM. (+)-Catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase activation in the min/+ mouse. Cancer Res 2001;61: 118-25.
38. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998;19: 1771-6.
39. Chen ZP, Schell JB, Ho CT, Chen KY. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett 1998;129:173-9.
40. Damianaki A, Bakogeorgou E, Kampa M, et al. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem 2000;78:429-41.
41. Chung LY, Cheung TC, Kong SK, et al. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci 2001;68:1207-14.
42. Elattar TM, Virji AS. The effect of red wine and its components on growth and proliferation of human oral squamous carcinoma cells. Anticancer Res 1999;19:5407-14.
43. Zhang G, Miura Y, Yagasaki K. Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity. Cancer Lett 2000;159:169-73.
44. Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol 2000;60:1051-9.
45. Talamini R, Franceschi S, Barra S, La Vecchia C. The role of alcohol in oral and pharyngeal cancer in non-smokers, and of tobacco in nondrinkers. Int J Cancer 1990;46:391-3.
46. MacFarlane GJ, Zheng T, Marshall JR, et al. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol 1995;31B:181-7.
47. Grønbaek M, Becker U, Johansen D, Tønnesen H, Jensen G, Sørensen TIA. Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 1998;317:844-8.
48. Tavani A, Ferraroni M, Mezzetti M, Franceschi S, LoRe A, LaVecchia C. Alcohol intake and risk of cancers of the colon and rectum. Nutr Cancer 1998;30:213-9.
49. Freudenheim JL, Marshall JR, Graham S, et al. Lifetime alcohol consumption and risk of breast cancer. Nutr Cancer 1995;23:1-11.
50. Longnecker MP, Newcomb PA, Mittendorf R, et al. Risk of breast cancer in relation to lifetime alcohol consumption. J Natl Cancer Inst 1995;87:923-9.
51. Levi F, Paxche C, Lucchini F, LaVecchia C. Alcohol and breast cancer in the Swiss Canton of Vaud. Eur J Cancer 1996;32A:2108-13.
52. Van den Brandt PA, Goldbohm A, Van't Veer P. Alcohol and breast cancer: results from the Netherlands cohort study. Am J Epidemiol 1995;141:907-15.
53. Viel JF, Perarnau JM, Challier B, Faivre-Nappez I. Alcoholic calories, red wine consumption and breast cancer among premenopausal women. Eur J Epidemiol 1997;13:639-43.